ESMC ESCALON MEDICAL CORP
Electromedical & Electrotherapeutic Apparatus · OTC · SEC CIK 862668 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY15.4%
TTM net income YoY4,528.3%
TTM EPS YoY1,700.0%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR81.5%
Margins
Gross margin44.1%
Operating margin3.8%
Net margin32.8%
FCF margin0.8%
EBITDA margin3.9%
Returns
ROE114.9%
ROA61.7%
ROIC (approx.)22.8%
Asset turnover1.88x
Leverage & solvency
Liabilities / assets38.4%
Debt / equity0.00x
Current ratio2.72x
Interest coverage149.58x
Cash quality & payout
Operating cash flow / net income0.03x
Accruals ratio60.2%
Payout ratio—
Capex / revenue0.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 | FY20242024-06-30 | FY20232023-06-30 | FY20222022-06-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $12.74M | $12.05M | $11.98M | $12.18M | $10.70M |
| Cost of revenue | $7.17M | $6.54M | $6.84M | $6.70M | $6.10M |
| Gross profit | $5.57M | $5.51M | $5.15M | $5.48M | $4.61M |
| R&D expense | $501,488 | $753,130 | $688,189 | $818,769 | $990,982 |
| SG&A expense | $5.02M | $4.62M | $4.56M | $4.18M | $4.09M |
| Operating income | $45,235 | $133,217 | -$104,476 | $478,543 | -$470,063 |
| Interest expense | $7,459 | $22,692 | $20,785 | $21,717 | $18,406 |
| Pretax income | $2.87M | $105,525 | — | — | — |
| Income tax | -$1.14M | $0 | $0 | $0 | $0 |
| Net income | $4.01M | $105,525 | -$125,261 | $456,826 | $18,081 |
| EBITDA | $67,823 | $171,036 | -$58,461 | $523,745 | -$421,631 |
| EPS (basic) | 0.27 | 0.00 | -0.02 | 0.03 | 0.00 |
| EPS (diluted) | 0.27 | 0.00 | -0.02 | 0.03 | 0.00 |
| Weighted avg. shares (diluted) | 14.60M | 14.25M | 7.42M | 13.56M | 13.22M |
| Balance sheet | |||||
| Cash & equivalents | $3.07M | $545,835 | $209,033 | $889,674 | $593,869 |
| Receivables | $1.90M | $1.50M | $2.12M | $1.65M | $1.54M |
| Inventory | $1.73M | $2.14M | $1.61M | $1.59M | $1.60M |
| Current assets | $7.01M | $4.61M | $4.40M | $4.64M | $4.19M |
| PP&E, net | $26,605 | $34,589 | $48,878 | $34,064 | $52,660 |
| Intangibles | $8,134 | $29,792 | $49,442 | $69,986 | $82,750 |
| Total assets | $9.13M | $4.99M | $4.76M | $5.31M | $5.17M |
| Current liabilities | $2.39M | $2.69M | $2.67M | $2.85M | $3.00M |
| Short-term debt | — | — | — | $0 | $201,575 |
| Total liabilities | $3.20M | $3.08M | $2.95M | $3.37M | $3.69M |
| Shareholders' equity | $5.93M | $1.92M | $1.81M | $1.93M | $1.48M |
| Shares outstanding | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M |
| Cash flow statement | |||||
| Operating cash flow | -$402,604 | $380,725 | -$602,771 | $325,146 | -$1.05M |
| Capital expenditure | $4,421 | $3,880 | $40,285 | $6,687 | $0 |
| Free cash flow | -$407,025 | $376,845 | -$643,056 | $318,459 | -$1.05M |
| Investing cash flow | $2.80M | -$3,880 | -$40,285 | -$13,842 | $0 |
| Financing cash flow | -$129,892 | -$39,915 | -$37,456 | -$15,371 | -$6,931 |
| Depreciation & amortization | $22,588 | $37,819 | $46,015 | $45,202 | $48,432 |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.